Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

计划入组 30 人 · 首次发布于 2023 年 12 月 11 日

Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects with Diabetic Macular Edema

计划入组 1 人 · 首次发布于 2023 年 1 月 26 日

Kamuvudine-9 (K9) in Diabetic Macular Edema

计划入组 10 人 · 首次发布于 2026 年 3 月 9 日

Kamuvudine-8

kamuvudine-9

Lactobacillus coryniformis K8

Hut 8 Corp

Canada

Phio Pharmaceuticals

United States

朗聪（北京）生物科技有限公司

Inflammasome Therapeutics' K8 Slows Geographic Atrophy Lesion Growth by 54% and Shows Visual-Acuity Benefit in Phase 2 Trial

Inflammasome Therapeutics' K8 Implant Reduces Geographic Atrophy Lesion Growth by 53% in Phase I Trial

Inflammasome Therapeutics' K8 Implant Shows Promise in Geographic Atrophy Trial